Sexual dysfunction in patients with psoriasis

Simple item page
dc.contributor.authorTürel Ermertcan A.
dc.contributor.authorTemeltaş G.
dc.contributor.authorDeveci A.
dc.contributor.authorDinç G.
dc.contributor.authorGüler H.B.
dc.contributor.authorÖztürkcan S.
dc.date.accessioned2024-07-22T08:23:09Z
dc.date.available2024-07-22T08:23:09Z
dc.date.issued2006
dc.description.abstractPsoriasis can have a significant impact upon sexual function. The aim of this study was to investigate sexual function in females and males with psoriasis and to evaluate whether coexistent depression has an additional negative effect on sexual function in these patients. A total of 66 female subjects (39 with psoriasis and 27 healthy volunteers as a control group) and 70 male subjects (39 with psoriasis and 31 healthy volunteers as a control group) were enrolled in the study. A Psoriasis Area and Severity Index (PASI) was used to determine the severity of psoriasis for the patient groups. The Female Sexual Function Index (FSFI) was used to assess female sexual function and the International Index of Erectile Function (IIEF) was used to evaluate male sexual function. Quality of life was assessed with the Dermatology Life Quality Index (DLQI). The diagnosis of depression was made according to the Structured Clinical Interview for DSM-IV (SCID-I) interview and Hamilton Depression Rate Scale (HDRS) was used for grading depression. FSFI total score was found to be significantly decreased in female psoriatic patients without depression and psoriatic patients plus depression compared with healthy controls (24.09 ± 5.33 vs. 24.25 ± 4.52 vs. 28.12 ± 3.48, respectively, p = 0.004). However, FSFI score was not significantly different between patients with psoriasis without depression and those with psoriasis plus depression (p > 0.05). IIEF total score was also found to be significantly decreased in male psoriasis without depression and psoriasis plus depression patients compared with healthy controls (54.21 ± 13.07 vs. 52.0 ± 14.73 vs. 61.69 ± 9.49, respectively, p = 0.023). The difference in IIEF scores between patients with psoriasis without depression and in those with psoriasis plus depression were not statistically significant (p > 0.05). The results of the study demonstrated that patients with psoriasis, especially females have distinct sexual dysfunction compared with healthy controls, and coexistent depression has no additional negative effect on sexual dysfunction in our patients. Patients with psoriasis should be evaluated in terms of sexual function in order to provide a better quality of life. © 2006 Japanese Dermatological Association.
dc.identifier.DOI-ID10.1111/j.1346-8138.2006.00179.x
dc.identifier.issn13468138
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/19396
dc.language.isoEnglish
dc.subjectAdult
dc.subjectCase-Control Studies
dc.subjectFemale
dc.subjectHumans
dc.subjectMale
dc.subjectPsoriasis
dc.subjectPsychiatric Status Rating Scales
dc.subjectQuality of Life
dc.subjectSeverity of Illness Index
dc.subjectSexual Dysfunctions, Psychological
dc.subjectadult
dc.subjectarticle
dc.subjectcomorbidity
dc.subjectcontrolled study
dc.subjectdepression
dc.subjectdiagnostic and statistical manual of mental disorders
dc.subjectdisease association
dc.subjectdisease severity
dc.subjecterectile dysfunction
dc.subjectfemale
dc.subjectfemale sexual dysfunction
dc.subjectHamilton scale
dc.subjecthuman
dc.subjectinterview
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectpsoriasis
dc.subjectquality of life
dc.subjectscoring system
dc.titleSexual dysfunction in patients with psoriasis
dc.typeArticle

Files

Collections

Scopus Koleksiyonu